IBS VA Rating Criteria: DC 7319 Defecation Pain and Associated Features Guide

Effective May 19, 2024, the Department of Veterans Affairs substantially modernized the rating criteria for digestive disorders in 38 CFR 4.114. Under the prior legacy schedule, IBS was evaluated using subjective categories of bowel distress (such as mild, moderate, or severe distress). That legacy framework no longer reflects current law for modern claims. Under current Diagnostic Code 7319, schedular percentages are determined strictly by objective clinical criteria: the documented frequency of abdominal pain related to defecation over a rolling three-month lookback period, combined with at least two of six specified accompanying bowel symptoms. Claims with effective dates prior to May 19, 2024, or staged rating reviews may involve legacy criteria, but all modern ratings are governed by the revised rule.

Diagnostic Code 7319 provides three compensable rating tiers: 10%, 20%, and 30%. A 10% rating is assigned when medical records document abdominal pain related to defecation at least once during the previous three months, accompanied by two or more qualifying bowel symptoms. A 20% rating requires documented abdominal pain related to defecation for at least three days per month during the previous three months, plus two or more qualifying symptoms. A 30% rating, which is the maximum schedular evaluation available under DC 7319, requires abdominal pain related to defecation at least one day per week during the previous three months, along with two or more accompanying symptoms. If documented symptoms fail to meet the lowest 10% threshold, a 0% noncompensable rating is assigned.

Under DC 7319, frequency of defecation-related pain alone is insufficient to support a compensable percentage; the veteran must also exhibit at least two of six specific associated features during the same three-month window. These six features are: (1) change in stool frequency, (2) change in stool form, (3) altered stool passage (such as straining or urgency), (4) mucorrhea (passage of mucus in stool), (5) abdominal bloating, or (6) subjective abdominal distension. Documenting only one associated symptom fails the regulatory threshold at every tier, whether the pain occurs once every three months or multiple times per week. Medical records and symptom logs must establish the concurrent presence of at least two distinct features from this enumerated list.

The official Note to DC 7319 clarifies that irritable bowel syndrome may encompass a spectrum of functional digestive disorders, specifically including functional dyspepsia, functional bloating, functional constipation, and functional diarrhea. However, this does not mean every functional gastrointestinal complaint automatically equals IBS. The Note explicitly instructs raters to evaluate other symptoms of a functional digestive disorder not encompassed by DC 7319 under the appropriate diagnostic code. In particular, gastrointestinal dysmotility syndrome is evaluated separately under Diagnostic Code 7356, which rates up to 80% based on dietary management, intestinal motility impairment, and nutritional support dependence. Any separate evaluations remain subject to the anti-pyramiding principles of 38 CFR 4.14 and the digestive non-combination rules of 38 CFR 4.114.

Under 38 CFR 3.317, medically unexplained chronic multisymptom illnesses (MUCMIs), including functional gastrointestinal disorders like IBS, qualify for presumptive service connection for Persian Gulf War veterans who served in the Southwest Asia theater of operations. When claiming IBS secondary to service-connected conditions such as PTSD, chronic anxiety, or orthopedic pain requiring long-term NSAID therapy, presumptive rules do not apply. For secondary service connection, Association between conditions does not by itself establish secondary service connection. The evidence must support causation or aggravation in the individual claim. Solid evidence includes a formal gastroenterology diagnosis, the VA Intestinal Conditions Disability Benefits Questionnaire, and a longitudinal three-month symptom diary logging dates of pain, stool characteristics, and associated symptoms.